SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-24-011813
Filing Date
2024-03-29
Accepted
2024-03-28 17:47:47
Documents
76
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm   iXBRL 10-K 1595742
2 ex4-1.htm EX-4.1 18624
3 ex21-1.htm EX-21.1 4671
4 ex23-1.htm EX-23.1 3349
5 ex31-1.htm EX-31.1 18487
6 ex31-2.htm EX-31.2 18446
7 ex32-1.htm EX-32.1 9822
8 ex97-1.htm EX-97.1 60618
  Complete submission text file 0001493152-24-011813.txt   7450352

Data Files

Seq Description Document Type Size
9 XBRL SCHEMA FILE ghsi-20231231.xsd EX-101.SCH 51284
10 XBRL CALCULATION FILE ghsi-20231231_cal.xml EX-101.CAL 65369
11 XBRL DEFINITION FILE ghsi-20231231_def.xml EX-101.DEF 243365
12 XBRL LABEL FILE ghsi-20231231_lab.xml EX-101.LAB 500941
13 XBRL PRESENTATION FILE ghsi-20231231_pre.xml EX-101.PRE 384967
80 EXTRACTED XBRL INSTANCE DOCUMENT form10-k_htm.xml XML 1058210
Mailing Address 2925 RICHMOND AVENUE SUITE 1200 HOUSTON TX 77098
Business Address 2925 RICHMOND AVENUE SUITE 1200 HOUSTON TX 77098 (800) 873-5141
Guardion Health Sciences, Inc. (Filer) CIK: 0001642375 (see all company filings)

IRS No.: 474428421 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38861 | Film No.: 24800789
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)